Allarity Therapeutics IncNASDAQ:ALLRNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.2325
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.2330/ 2
- Ask / Lots0.2450/ 8
- Open / Previous Close0.0000 / 0.2325
- Day Range---
- 52 Week Range
- Volume4,666
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ALLR |
|---|---|---|
| 09:32 ET | 27564 | 0.2443 |
| 09:33 ET | 16883 | 0.244 |
| 09:35 ET | 19047 | 0.2352 |
| 09:37 ET | 29292 | 0.2343 |
| 09:39 ET | 13320 | 0.235 |
| 09:42 ET | 10500 | 0.2355 |
| 09:44 ET | 14909 | 0.2348 |
| 09:46 ET | 13979 | 0.236 |
| 09:48 ET | 12733 | 0.236 |
| 09:50 ET | 46715 | 0.2341 |
| 09:51 ET | 8987 | 0.2341 |
| 09:53 ET | 15200 | 0.2343 |
| 09:55 ET | 24046 | 0.2338 |
| 09:57 ET | 23258 | 0.2321 |
| 10:00 ET | 3322 | 0.2337 |
| 10:02 ET | 14793 | 0.2329 |
| 10:04 ET | 19196 | 0.2321 |
| 10:06 ET | 13173 | 0.2321 |
| 10:08 ET | 41802 | 0.23 |
| 10:09 ET | 8400 | 0.2301 |
| 10:11 ET | 19545 | 0.2313 |
| 10:13 ET | 18310 | 0.230106 |
| 10:15 ET | 9550 | 0.2312 |
| 10:18 ET | 139149 | 0.2315 |
| 10:20 ET | 27000 | 0.232 |
| 10:22 ET | 68971 | 0.2335 |
| 10:24 ET | 12162 | 0.235 |
| 10:26 ET | 90300 | 0.2325 |
| 10:27 ET | 25950 | 0.2327 |
| 10:29 ET | 800 | 0.2327 |
| 10:31 ET | 28984 | 0.2313 |
| 10:33 ET | 17604 | 0.2306 |
| 10:36 ET | 11487 | 0.2303 |
| 10:38 ET | 7100 | 0.2311 |
| 10:40 ET | 96352 | 0.2351 |
| 10:42 ET | 74924 | 0.244 |
| 10:44 ET | 44796 | 0.2404 |
| 10:45 ET | 42881 | 0.2371 |
| 10:47 ET | 36979 | 0.234 |
| 10:49 ET | 6600 | 0.2331 |
| 10:51 ET | 7400 | 0.233 |
| 10:54 ET | 4900 | 0.2365 |
| 10:56 ET | 1968 | 0.2332 |
| 10:58 ET | 17200 | 0.2334 |
| 11:00 ET | 2723 | 0.2335 |
| 11:02 ET | 1617 | 0.2332 |
| 11:03 ET | 24700 | 0.2337 |
| 11:05 ET | 12424 | 0.2338 |
| 11:07 ET | 4033 | 0.234701 |
| 11:09 ET | 62038 | 0.2351 |
| 11:12 ET | 19810 | 0.2312 |
| 11:14 ET | 35476 | 0.232 |
| 11:16 ET | 9150 | 0.2351 |
| 11:18 ET | 34106 | 0.232 |
| 11:20 ET | 12700 | 0.2321 |
| 11:21 ET | 9500 | 0.232 |
| 11:23 ET | 8165 | 0.2314 |
| 11:25 ET | 102636 | 0.23 |
| 11:27 ET | 22315 | 0.23 |
| 11:30 ET | 7310 | 0.23 |
| 11:32 ET | 54896 | 0.2301 |
| 11:34 ET | 22698 | 0.231 |
| 11:36 ET | 2600 | 0.232 |
| 11:39 ET | 2344 | 0.2305 |
| 11:41 ET | 11783 | 0.230286 |
| 11:43 ET | 12758 | 0.2302 |
| 11:45 ET | 5600 | 0.231 |
| 11:48 ET | 17478 | 0.2327 |
| 11:50 ET | 9500 | 0.232 |
| 11:52 ET | 177322 | 0.2289 |
| 11:54 ET | 4050 | 0.2289 |
| 11:56 ET | 6150 | 0.2288 |
| 11:57 ET | 16250 | 0.228801 |
| 11:59 ET | 3500 | 0.2304 |
| 12:01 ET | 26379 | 0.2288 |
| 12:03 ET | 7200 | 0.2288 |
| 12:06 ET | 2677 | 0.2288 |
| 12:08 ET | 800 | 0.2287 |
| 12:10 ET | 21050 | 0.229 |
| 12:12 ET | 52937 | 0.2265 |
| 12:14 ET | 10238 | 0.2266 |
| 12:15 ET | 1300 | 0.2266 |
| 12:17 ET | 2900 | 0.2349 |
| 12:19 ET | 10200 | 0.2271 |
| 12:21 ET | 600 | 0.228 |
| 12:24 ET | 16200 | 0.2285 |
| 12:26 ET | 1400 | 0.2285 |
| 12:28 ET | 10000 | 0.2285 |
| 12:30 ET | 39897 | 0.2285 |
| 12:32 ET | 1700 | 0.229 |
| 12:33 ET | 2100 | 0.229 |
| 12:35 ET | 4635 | 0.231981 |
| 12:37 ET | 5900 | 0.2291 |
| 12:39 ET | 65615 | 0.2275 |
| 12:42 ET | 3675 | 0.2275 |
| 12:44 ET | 4150 | 0.2275 |
| 12:46 ET | 1100 | 0.2275 |
| 12:48 ET | 5010 | 0.2298 |
| 12:50 ET | 4900 | 0.2275 |
| 12:51 ET | 1800 | 0.2291 |
| 12:53 ET | 7600 | 0.2291 |
| 12:55 ET | 22600 | 0.2322 |
| 12:57 ET | 10900 | 0.2323 |
| 01:00 ET | 1600 | 0.234 |
| 01:02 ET | 1800 | 0.232 |
| 01:04 ET | 1300 | 0.232 |
| 01:06 ET | 4510 | 0.2323 |
| 01:08 ET | 2200 | 0.232 |
| 01:09 ET | 5700 | 0.2293 |
| 01:11 ET | 15694 | 0.2305 |
| 01:13 ET | 7200 | 0.23 |
| 01:15 ET | 1000 | 0.2291 |
| 01:18 ET | 11164 | 0.2293 |
| 01:20 ET | 1000 | 0.2293 |
| 01:22 ET | 1668 | 0.231899 |
| 01:24 ET | 3833 | 0.232 |
| 01:26 ET | 2234 | 0.23 |
| 01:27 ET | 1100 | 0.23 |
| 01:29 ET | 33804 | 0.2294 |
| 01:31 ET | 1000 | 0.2294 |
| 01:33 ET | 1100 | 0.2294 |
| 01:36 ET | 2778 | 0.2299 |
| 01:38 ET | 1400 | 0.2299 |
| 01:40 ET | 800 | 0.231 |
| 01:42 ET | 22650 | 0.232 |
| 01:44 ET | 9973 | 0.2319 |
| 01:45 ET | 1093 | 0.2319 |
| 01:47 ET | 2400 | 0.2319 |
| 01:49 ET | 1000 | 0.2319 |
| 01:51 ET | 1998 | 0.2319 |
| 01:54 ET | 5497 | 0.2319 |
| 01:56 ET | 900 | 0.2319 |
| 01:58 ET | 10255 | 0.2319 |
| 02:00 ET | 13712 | 0.2319 |
| 02:02 ET | 800 | 0.2319 |
| 02:03 ET | 11800 | 0.232 |
| 02:05 ET | 729 | 0.232 |
| 02:07 ET | 2348 | 0.232 |
| 02:09 ET | 2600 | 0.232 |
| 02:12 ET | 2500 | 0.2321 |
| 02:14 ET | 100 | 0.2339 |
| 02:16 ET | 800 | 0.2321 |
| 02:18 ET | 2839 | 0.232 |
| 02:20 ET | 2519 | 0.2321 |
| 02:21 ET | 8800 | 0.232 |
| 02:23 ET | 4648 | 0.232 |
| 02:25 ET | 7400 | 0.232 |
| 02:27 ET | 12500 | 0.2319 |
| 02:30 ET | 13107 | 0.232 |
| 02:32 ET | 1202 | 0.232 |
| 02:34 ET | 2593 | 0.232 |
| 02:36 ET | 2214 | 0.232 |
| 02:39 ET | 1200 | 0.232 |
| 02:41 ET | 2012 | 0.232 |
| 02:43 ET | 6949 | 0.2321 |
| 02:45 ET | 18500 | 0.2329 |
| 02:48 ET | 17163 | 0.2319 |
| 02:50 ET | 600 | 0.2319 |
| 02:52 ET | 5405 | 0.2319 |
| 02:54 ET | 4531 | 0.2319 |
| 02:56 ET | 3200 | 0.2319 |
| 02:57 ET | 1400 | 0.2319 |
| 02:59 ET | 22904 | 0.2319 |
| 03:01 ET | 12167 | 0.2282 |
| 03:03 ET | 2745 | 0.2283 |
| 03:06 ET | 9400 | 0.2286 |
| 03:08 ET | 2600 | 0.2286 |
| 03:10 ET | 2220 | 0.2286 |
| 03:12 ET | 1300 | 0.2288 |
| 03:14 ET | 14000 | 0.2288 |
| 03:15 ET | 1180 | 0.2287 |
| 03:17 ET | 1480 | 0.2291 |
| 03:19 ET | 1700 | 0.2291 |
| 03:21 ET | 8260 | 0.2301 |
| 03:24 ET | 1500 | 0.2301 |
| 03:26 ET | 5001 | 0.2301 |
| 03:28 ET | 50980 | 0.229 |
| 03:30 ET | 12019 | 0.229 |
| 03:32 ET | 3501 | 0.2291 |
| 03:33 ET | 2100 | 0.2293 |
| 03:35 ET | 6700 | 0.2295 |
| 03:37 ET | 2100 | 0.2295 |
| 03:39 ET | 5225 | 0.2311 |
| 03:42 ET | 19650 | 0.2295 |
| 03:44 ET | 20478 | 0.2287 |
| 03:46 ET | 3310 | 0.2287 |
| 03:48 ET | 6194 | 0.2287 |
| 03:50 ET | 4899 | 0.2286 |
| 03:51 ET | 4145 | 0.228 |
| 03:53 ET | 16083 | 0.2275 |
| 03:55 ET | 11926 | 0.2275 |
| 03:57 ET | 15643 | 0.2285 |
| 04:00 ET | 13400 | 0.2325 |
Jan 24, 2023
Top Premarket Decliners, from 7:49AM ET on Tuesday Jan 24, 2023 by MT Newswires
7:49AM ET on Tuesday Jan 24, 2023 by MT Newswires
Jan 23, 2023
Thinking about buying stock in Helbiz, General Electric, Allarity Therapeutics, Bed Bath & Beyond, or Lucid Group?, from 10:53AM ET on Monday Jan 23, 2023 by PR Newswire
10:53AM ET on Monday Jan 23, 2023 by PR NewswireTop Premarket Gainers, from 7:52AM ET on Monday Jan 23, 2023 by MT Newswires
7:52AM ET on Monday Jan 23, 2023 by MT Newswires
Jan 20, 2023
BRIEF-Allarity Therapeutics Inc's Board Decreases Number Of Authorized Directors 7 To 5, from 4:22PM ET on Friday Jan 20, 2023 by Thomson Reuters
4:22PM ET on Friday Jan 20, 2023 by Thomson ReutersBRIEF-Allarity Therapeutics Announces Adjournment Of 2023 Annual Meeting Of Stockholders, from 4:02PM ET on Friday Jan 20, 2023 by Thomson Reuters
4:02PM ET on Friday Jan 20, 2023 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Allarity Therapeutics Inc | 5.7M | -0.1x | --- |
First Wave BioPharma Inc | 5.7M | 0.0x | --- |
Virios Therapeutics Inc | 5.8M | -0.2x | --- |
Capstone Holding Corp | 5.8M | -5.6x | --- |
Enveric Biosciences Inc | 5.9M | 0.0x | --- |
Aclarion Inc | 5.7M | 0.0x | --- |
Company Information
Allarity Therapeutics, Inc. is a clinical-stage precision medicine company. The Company is engaged in targeting some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates together with its Drug Response Predictor (DRP) companion diagnostics in a precision medicine approach. The Company's products include dovitinib, stenoparib, and IXEMPRA (ixabepilone). The lead therapeutic candidate, dovitinib, is a selective inhibitor of several classes of tyrosine kinases, including FGFR and VEGFR. The therapeutic candidate is stenoparib is a novel inhibitor of the key deoxyribonucleic acid (DNA) damage repair enzyme poly-ADP-ribose polymerase (PARP). The therapeutic candidate is IXEMPRA (ixabepilone) is a selective microtubule inhibitor. The DRP technology is a diagnostic platform that models human tumor biology and can help predict whether a cancer patient respond or not to a particular drug.
Contact Information
- Headquarters
- 24 School St., 2Nd FloorBOSTON, MA, United States 02108
- Phone
- 401-426-4664
- Fax
- 302-655-5049
Executives
- Interim Chief Executive Officer, Chief Business Officer
- James Cullem
- Interim Chief Financial Officer
- Joan Brown
- Senior Vice President of Investor Relations, Executive Director
- Thomas Jensen
- Chief Scientific Officer
- Steen Knudsen
- Chief Medical Officer
- Marie Foegh
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 24.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-4.58 |
Book Value | $2.32 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
